Humacyte Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	609	294	218	747	131	-
Market Cap Growth	15.99%	35.19%	-70.86%	471.21%	-	-
Enterprise Value	570	271	116	572	120	-66
PE Ratio	-	-2.65	-18.18	-28.20	-1.96	-
PS Ratio	-	-	139.03	591.27	87.68	-
PB Ratio	23.27	21.72	1.86	6.11	-0.37	-
P/FCF Ratio	-4.43	-3.89	-3.01	-9.17	-2.34	-
P/OCF Ratio	-4.52	-4.01	-3.06	-9.20	-2.35	-
EV/Sales Ratio	-	-	73.97	453.25	80.26	-10.75
EV/EBITDA Ratio	-3.62	-2.81	46.49	-41.34	-2.14	0.87
EV/EBIT Ratio	-3.35	-2.60	-20.08	-25.87	-1.86	0.80
EV/FCF Ratio	-3.97	-3.59	-1.60	-7.03	-2.14	0.83
Debt / Equity Ratio	2.93	4.25	0.43	0.42	-0.08	-0.09
Debt / EBITDA Ratio	-0.84	-0.60	20.11	-3.70	-0.52	-0.36
Debt / FCF Ratio	-0.92	-0.76	-0.69	-0.63	-0.52	-0.34
Quick Ratio	8.20	4.36	7.76	20.42	3.56	8.70
Current Ratio	8.37	4.51	7.88	20.76	3.69	8.76
Asset Turnover	0	0	0.01	0.01	0.01	-
Interest Coverage	-14.74	-15.79	-0.93	-5.09	-29.21	-36.17
Return on Equity (ROE)	-306.80%	-228.90%	-9.90%	19.40%	20.80%	-
Return on Assets (ROA)	-69.60%	-70.50%	-5.10%	-13.30%	-48.30%	-
Return on Capital (ROIC)	-101.40%	-140.81%	-50.65%	-46.85%	20.10%	32.76%
Earnings Yield	-17.37%	-37.66%	-5.50%	-3.55%	-50.88%	-
FCF Yield	-13.73%	-25.70%	-33.17%	-10.90%	-42.71%	-
Buyback Yield / Dilution	-4.83%	-0.36%	-157.82%	-593.25%	71.34%	-
Total Shareholder Return	-4.83%	-0.36%	-157.82%	-593.25%	71.34%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).